At Crescenta, we are harnessing the power of immunometabolism and merging it with the advantages of small molecule therapy, with one overarching goal: to improve human health globally.

​

Our discovery platform centers on a new concept: modulating the immune response by specifically targeting the biological functions associated with “lipid binding proteins”. Utilizing this platform, we are developing first-in-class drugs to address diseases and conditions that pose significant challenges to current medical practices. (Pipeline)

​

Working with globally renowned scientists and business experts who are not only leaders in their respective fields but also embody the highest standards of compassion and integrity, we are advancing our transformative drugs through clinical development and toward commercialization. (Our team)